Umbilical Cord Allograft for Musculoskeletal Pain/Injuries

Recruiting in Palo Alto (17 mi)

+1 other location

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: R3 Stem Cell

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing an amniotic fluid product to see if it can reduce pain and improve function in people with muscle and joint problems. The product uses natural substances found in amniotic fluid to reduce inflammation and possibly help heal tissues. It is aimed at patients who do not respond well to regular pain treatments.

Research Team

Eligibility Criteria

This trial is for adults over 18 with various musculoskeletal conditions like pelvic pain, sports injuries, arthritis, and more. Participants must understand the study and consent to it, as well as commit to follow-up visits or remote check-ins. Pregnant or breastfeeding individuals, those with active infections or clotting disorders cannot join.

Inclusion Criteria

I am 18 years old or older.

I understand the study details and agree to participate voluntarily.

I am 18 years old or older.

See 3 more

Exclusion Criteria

Lactating

Pregnancy

I have a blood clotting disorder.

See 1 more

Treatment Details

Interventions

Amniotic (Regenerative Medicine)
Umbilical Allograft (Other)

Trial OverviewThe trial is testing an Amniotic Fluid Tissue Product (Umbilical Allograft) for relieving pain and improving function in musculoskeletal conditions. It's a forward-looking study that will measure outcomes at different times after the treatment.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Umbilical AllograftExperimental Treatment1 Intervention

The study is nonrandomized with one arm. Depending on the body area being treated, the amount of the product utilized will be either 1.0cc's or 2cc's.